S-1/A: Cosmos Health Inc. Files Amendment No. 4 to Form S-1 Registration Statement
S-1/A Amendment Filing
Cosmos Health Inc. files an amendment to its Form S-1 registration statement, updating exhibits related to legal and accounting consents.
Summary
- Cosmos Health Inc. filed Amendment No. 4 to its Form S-1/A registration statement with the Securities and Exchange Commission on February 7, 2025.
- The amendment primarily updates Exhibits 23.1 and 23.2, which are the consents of Armanino LLP and RBSM LLP, the company's independent registered public accounting firms.
- The filing includes the facing page, an explanatory note, Item 16(a) of Part II, the signature page, and the updated exhibits.
- The remainder of the registration statement remains unchanged.
- The company intends to commence the proposed sale to the public as soon as practicable after the registration statement becomes effective.
Sentiment
Score: 6
Explanation: The document is a routine regulatory filing, so the sentiment is neutral. It's a necessary step for the company's financial activities.
Future Outlook
The company intends to commence the proposed sale to the public as soon as practicable after the registration statement becomes effective.
Industry Context
This filing is a standard part of the process for companies seeking to raise capital through public offerings, ensuring transparency and compliance with SEC regulations.
Stakeholder Impact
- The filing is relevant to potential investors as it provides updated information related to the company's financial statements and offering.
- The effectiveness of the registration statement is crucial for the company to proceed with its capital raising plans.
Next Steps
- The SEC will review the registration statement.
- The company will proceed with the public offering once the registration statement is declared effective.
Key Dates
| Date | Description |
|---|---|
| February 24, 2022 | Correction to Certificate of Designations of Rights and Preferences of Series A Convertible Preferred Stock |
| April 12, 2023 | Date of Armanino LLP's report relating to the consolidated financial statements for the year ended December 31, 2022 |
| August 5, 2024 | Date of RBSM LLP's report with respect to the audited consolidated financial statements for the year ended December 31, 2023 |
| February 7, 2025 | Date of filing Amendment No. 4 to Form S-1/A |
Keywords
Registration Statement, Form S-1/A, Amendment, Cosmos Health Inc., Securities and Exchange Commission, Exhibits, Consent, Armanino LLP, RBSM LLP, Accounting Firm, Offering
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.